clinical efficacies were evaluable in 58 patients among them ( consisting of 2 patients with sepsis , 3 with tonsillitis , 12 with bronchitis , 6 with bronchopneumonia , 24 with pneumonia , 1 with phlegmon , 2 with lymphadenitis , 1 with impetigo and 7 with urinary tract infection ) and were excellent in 40 patients and good in 17 with an overall efficacy rate of 98.3 % .
C0006285
bronchopneumonia
C0032285
pneumonia